Exclusive | Women are getting work done to fix their Ozempic temples including Melissa Rivers

Joan Rivers would have loved Ozempic, according to her daughter, Melissa Rivers.Melissa would know — she’s been on a GLP-1 herself.After realizing her metabolism had slowed during menopause, the 58-year-old TV correspondent went on Mounjaro and lost 25 pounds over six months, she revealed to The Post.“Everything that used to work wasn’t working any longer,” she said.But there was one downside: She suddenly experienced temporal hollowing, also known as temporal wasting, in which rapid weight loss leads to a loss of volume in the temples, potentially aging the face.“I always had a close eye on my temples, even before the weight loss, because I’m narrow in that area naturally … but it just became a bigger issue afterwards,” Rivers said.To save face — literally — she turned to Lisa Goodman, a pioneer in regenerative aesthetics and the founder of GoodSkin Clinics, to add volume back with NuvaSculpt and Xerf.

The former combines localized fat growth with tightening and firming, while the latter uses radiofrequency for skin-tightening and lifting.“It’s about having a soft touch; nothing was ever dramatic,” Rivers explained.“It was literally progressive, and I became a laser junkie — it’s become a sickness.” “It made a world of difference,” she added. Rivers is far from the first person to find that weight loss success on a GLP-1 drug can also be aging — and she’s certainly not the only one getting procedures to fix it.

Some are even fully going under the knife.“Temporal hollowing is part of the aging process — fat atrophies as we get older,” explained Dr.Anthony Berlet, founder of Berlet Plastic Surgery in NYC and New Jersey.

“But when you’re on a GLP-1 like Ozempic and losing a lot of weight suddenly, the loss of facial fat can make you appear to age prematurely, and we have to put volume back where it’s supposed to be.”After losing 50 pounds over the course of six months on Ozempic, 33-year-old Veruzka Scavo ...